Jacob Nadav Ablin

Jacob Nadav Ablin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jacob Nadav Ablin has a total of 344 co-authors. Here are the top co-authors by number of shared publications:

  • Dan Buskila

    Ben Gurion University of the Negev, Beersheeba, Israel

    23 shared publications
  • Valerie Aloush

    Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv

    15 shared publications
  • Ori Elkayam

    Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    11 shared publications
  • Dan Buskila

    Department of Medicine H, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel

    9 shared publications
  • Winfried Häuser

    Klinik für Psychosomatische Medizin und Psychotherapie, Johannes-Gutenberg Universität Mainz, Mainz, Deutschland

    9 shared publications
  • Dan Caspi

    Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    8 shared publications

Latest Publications

  • Open Access

    Treat-to-target weight management in fibromyalgia: a preliminary estimate of clinically meaningful weight loss

    by Jacopo Ciaffi, Jacob N Ablin, Valerie Aloush, Roberto Caporali, Francesco Ursini

  • Systemic Challenges in EHR Alert Design: A Thematic Analysis of Physician Discourse on X (Formerly Twitter)

    by Guy Vishnevsky, Jacob N. Ablin

    Background Electronic health record (EHR) clinical decision support (CDS) systems generate excessive, non-contextual alerts, causing clinician desensitization with override rates exceeding 90%. This alert fatigue disrupts workflows, contributes to burnout, and creates patient safety risks. Traditional survey-based methods fail to capture real-time end-user feedback at scale. Objectives This study aimed to evaluate real-world CDS usability signals by analyzing physician discourse on X (formerly Twitter) and identify physician-perceived sociotechnical pain points to inform future, hypothesis-driven EHR optimization. Methods X was systematically searched in August 2025 using Grok 4 (2025-08 build) via an internal API (Application Programming Interface). The AI temperature was set to 0.7 for search generation to ensure a broad retrieval of relevant discourse, utilizing keywords including “EHR alert fatigue,” “clinical decision support usability,” “EMR burnout,” “override EHR,” and “alert fatigue doctors,” yielding 117 posts from 106 self-identified physicians after manual curation (spanning from 2016 to 2025). Only the first post per author was included in the final analysis of 106 posts. We applied Braun and Clarke’s reflexive thematic analysis, with artificial intelligence (AI)-assisted coding verification. Sentiment classification was conducted as a secondary assessment. Results Six CDS usability failure domains were identified: Alert Overwhelm (38.7%, 95% confidence interval [CI]: 30.0–48.2%), Burnout and Fatigue (43.4%, 95% CI: 34.4–52.9%), Patient Safety Threats (9.4%, 95% CI: 5.2–16.5%), Regulatory and Billing Pressures (17.0%, 95% CI: 11.0–25.3%), Mitigation Strategies, including AI prioritization (36.8%, 95% CI: 28.2–46.3%), and Lack of Customization (7.5%, 95% CI: 3.9–14.2%). Sentiment was 76.4% (95% CI: 67.5–83.5%) negative. Co-occurrence analysis showed 50.0% of safety posts co-occurred with alert overwhelm, and 19.6% of burnout posts co-occurred with regulatory and billing pressures. Conclusion Physician discourse on X provides valuable, exploratory usability signals. The prevalence of alert overwhelm and burnout themes highlights recurring pain points in current EHR architectures, generating hypotheses for future user-centered CDS redesign such as tiered alerting, role-based routing, and alert deferral mechanisms.

  • Open Access

    “You Could Have Prevented It!“: attributions of responsibility toward COVID-19 unvaccinated vs. vaccinated individuals

    by Omer Pines, Jacob N. Ablin, Odelia Elkana

    While most of the population was vaccinated against COVID-19, ongoing vaccine hesitancy led to a substantial proportion of the population remaining unvacci

  • Via Dolorosa: impact of nociplastic pain on hospitalisation outcomes. A retrospective cohort study

    by Idan Ben Shabat, Shai Shtorzberg, Michal Hoffman Ben Shabat, Jacob N. Ablin

    Nociplastic pain, characterised by altered central pain processing, is associated with increased healthcare utilisation. This study investigated the relationship between nociplastic pain, based on clinical diagnoses of fibromyalgia, chronic pain, or myofascial pain, and hospital outcomes in patients. A retrospective cohort study was conducted using hospital records of hospitalised patients. Patients aged ≥18 years with a diagnosis of fibromyalgia, chronic pain, or myofascial pain were classified as the research group, while a comparison group of hospitalised patients without these diagnoses was selected. Outcomes included length of stay (LOS) for the index hospitalisation, recurrent hospitalisations within 6 months, Opioid use disorder (OUD), and 5-year mortality. Statistical analyses included t-tests, Wilcoxon tests, linear and Poisson regressions, adjusting for age and sex. Of 18,393 patients, 3,326 (18.1%) were in the research group. The research group was older (mean age 62.35 vs. 50.57 years, p<0.001) and had a higher proportion of females (72.7% vs. 56.6%). Adjusted analyses showed longer LOS in the research group (mean 6.89 vs. 5.59 days, p=0.002), higher recurrent hospitalisations (p<0.001), and increased OUD (87.5% of cases in the research group, p<0.001). Surprisingly, 5-year mortality risk was lower in the research group (HR 0.523, p<0.001). Nociplastic pain diagnoses are associated with prolonged hospitalisations, increased readmissions, and OUD, but lower long-term mortality. These findings highlight the need for targeted pain management strategies.

  • Open Access

    Fibromyalgia: are you a genetic/environmental disease?

    by Jacob N. Ablin

    Fibromyalgia, characterized by chronic widespread pain and fatigue, involves complex interactions between genetic predispositions and environmental triggers. This review delves into the multifaceted nature of fibromyalgia, emphasizing recent advances in understanding its pathogenesis through genetic, epigenetic, and environmental lenses. We explore the roles of specific genetic polymorphisms, such as those in the catechol-O-methyltransferase and serotonin transporter genes, and their correlation with the syndrome's susceptibility. The review also examines the significant impact of environmental factors, including physical trauma and stress, which potentiate the syndrome's severity. In addition, emerging research on the microbiome and epigenetic modifications provides new insights into the disease mechanisms, potentially guiding future therapeutic strategies. This article aims to synthesize current research findings and propose directions for future research, underscoring the necessity of a multidisciplinary approach to decipher the complexities of fibromyalgia.


  • Top Cited Papers
    Open Access

    Nociplastic Pain: A Critical Paradigm for Multidisciplinary Recognition and Management

    by Jacob N. Ablin

    Our understanding of chronic pain has evolved significantly, shifting from a focus on peripheral damage to recognizing the central mechanisms underlying pain perception. This perspective article explores the concept of nociplastic pain, a term introduced by the International Association for the Study of Pain (IASP) in 2017, which describes pain arising from altered pain modulation within the central nervous system, without clear evidence of tissue damage or inflammation. The historical progression from fibrositis to fibromyalgia, and now to nociplastic pain, underscores the complexity of chronic pain syndromes and the need for a multidisciplinary approach to management. Nociplastic pain is characterized by central sensitization, leading to heightened pain sensitivity and often accompanied by comorbidities such as fatigue, sleep disturbances, and cognitive difficulties. Advances in neuroimaging have revealed altered connectivity within key brain networks, such as the default mode and salience networks, in patients with nociplastic pain, providing insights into the neural underpinnings of this condition. The article also addresses controversies surrounding the role of small fiber neuropathy and autonomic dysfunction in nociplastic pain, highlighting the ongoing debates in the field. The practical importance of recognizing nociplastic pain across various medical disciplines—including primary care, orthopedics, neurology, psychiatry, and rheumatology—is emphasized, with recommendations for integrating this knowledge into clinical practice. Emerging therapies, such as neurofeedback, hyperbaric oxygen therapy, and neuromodulation, offer new avenues for treatment, particularly for patients who do not respond to conventional approaches. The article calls for continued research into the mechanisms of nociplastic pain, the development of reliable diagnostic tools, and the exploration of novel therapeutic strategies to improve patient outcomes. The recognition and management of nociplastic pain are crucial for advancing the care of patients with chronic pain, necessitating interdisciplinary collaboration and a patient-centered approach.


  • Open Access

    Cardiac Sarcoma Mimicking Libman–Sacks Endocarditis in a Patient with Systemic Lupus Erythematosus (SLE): A Case Report and Literature Review

    by Einat Ritter, Tamar Itach, Daphna Paran, Aleksandr Gaskin, Ofer Havakuk, Jacob Nadav Ablin

    We present the case of a 39-year-old woman who was diagnosed with SLE and antiphospholipid antibodies 8 years ago. The chief manifestations of her disease included low-grade fever and polyarthritis. Eight months before presentation, she experienced symptoms attributed to a flare of SLE, leading to an increase in immunomodulatory treatment with no improvement. She presented to the emergency room with acute onset of dyspnea. Clubbing of her fingers and toes was noted. When questioned, she reported the onset of clubbing 5 months earlier. A CTA was performed to rule out pulmonary embolism, which was excluded, although it revealed a severely damaged mitral valve with severe insufficiency and a large mass on the valve, protruding into the left atrium. Antibiotics were started, with a working diagnosis of infectious endocarditis; however, the severe mitral valve dysfunction lead to emergency mitral valve replacement, revealing an organized thrombus. She was treated with anticoagulation, with a working diagnosis of Libman–Sacks endocarditis, with no improvement. Additional immunosuppression failed to improve her symptoms. Enlargement of the thrombotic mass and an increased gradient across the prosthetic mitral valve led to repeat surgery, culminating in a diagnosis of high-grade sarcoma within the left atrial mass. We further discuss cardiac sarcoma and describe the occurrence of clubbing in patients with sarcoma. This case highlights the importance of interdisciplinary collaboration and the need for vigilant monitoring in refractory cases, particularly when atypical presentations arise.


  • Open Access

    Long COVID-19 Enigma: Unmasking the Role of Distinctive Personality Profiles as Risk Factors

    by Dana Amsterdam, Aviv Kupershmidt, Asia Avinir, Ron Matalon, Ofir Ohana, Omri Feder, Shai Shtrozberg, Guy Choshen, Jacob Nadav Ablin, Odelia Elkana

    Background: The COVID-19 (Coronavirus disease 2019) pandemic has prompted extensive research into lingering effects, especially in ‘Long COVID’ patients. Despite exploration, contributing factors remain elusive; Objective: This study explores the potential link between distinctive personality profiles, particularly type D personality, and an increased risk of Long COVID; Methods: A retrospective cross-sectional study at Tel-Aviv Sourasky Medical Center’s Post-COVID clinic analyzed data from 373 Long COVID patients through comprehensive questionnaires covering Long COVID syndrome, Fibromyalgia criteria, personality assessments, social support, and subjective evaluations of cognitive decline, health and life quality. In total, 116 out of 373 patients completed the questionnaire, yielding a 31% participation rate; Results: Cluster analysis revealed two groups, with Cluster 1 (N = 58) exhibiting Type D personality traits while Cluster 2 (N = 56) not meeting criteria for Type D personality. In comparison to Cluster 2, Cluster 1 patients reported heightened anxiety, depression, reduced social support, increased pain symptoms, manifestations of fibromyalgia, cognitive decline, and poor sleep quality, contributing to a diminished quality-of-life perception; Conclusions: findings highlight diverse personality profiles among Long COVID patients, emphasizing the need for tailored care. This approach shows potential for improving Long COVID patient care, aligning with the evolving personalized medicine paradigm.


  • TMS in combination with a pain directed intervention for the treatment of fibromyalgia - A randomized, double-blind, sham-controlled trial

    by Einat Tilbor, Aviad Hadar, Victor Portnoy, Ori Ganor, Yoram Braw, Howard Amital, Jacob Ablin, Chen Dror, Yuval Bloch, Uri Nitzan


  • Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects

    by Suzy E. Meijer, Ora Halutz, Amos Adler, Katya Levytskyi, Luba Tau, Michal Dekel, Ronit Cohen-Poradosu, Evgene Katchman, David Shasha, Jacob Ablin, et al.